๐ GENMAB STOCK SOARS 34%+! ๐งฌ๐
๐ฅ Genmab ($GMAB) surged +34.05% to $59.81, hitting a record high!
๐งช The catalyst: New cancer drug results showed a 50% reduction in the risk of death โ a major development in cancer treatment.
๐ฌ Investors are watching closely as promising clinical results fuel optimism for Genmabโs future.
๐ Can this biotech rally continue?
๐ฌ Would you invest in biotech stocks?